Current GI symptoms : Mention any active gastrointestinal symptoms (nausea, vomiting, bloating) and whether you're in a dose-escalation phase, as these factors may influence perioperative planning
doi:10.1210/clinem/dgae584 Gofron, K
doi:10.1016/j.jacc.2021.06.011
Many patients arrive with concerns influenced by online discussions or outdated information
Semaglutide and the other GLP-1 agonists have the added benefit of central effects on the hunger centres in the hypothalamus as well as delaying gastric emptying to increase fullness and suppress appetite, a valuable tool for both the treatment of diabetes and weight loss management, but a potential risk for the use of sedation/anaesthesia
Wharton S, Calanna S, Davies M, Dicker D, Goldman B, Lingvay I